Metrics to compare | 688712 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688712PeersSector | |
|---|---|---|---|---|
P/E Ratio | 105.5x | 65.9x | −0.4x | |
PEG Ratio | 0.32 | −1.09 | 0.00 | |
Price/Book | 7.2x | 2.4x | 2.6x | |
Price / LTM Sales | 19.4x | 6.0x | 3.1x | |
Upside (Analyst Target) | - | 50.1% | 48.9% | |
Fair Value Upside | Unlock | −9.0% | 6.8% | Unlock |
Insight Lifetech Co., Ltd. engages in research, development, production, and sales of interventional medical devices in the field of precision diagnosis and treatment of cardiovascular diseases in China and internationally. The company provides Coronary intervention products, including precision and complex percutaneous coronary intervention products, such as intracavitary imaging and physiological function products; peripheral vascular interventional diagnostic and treatment products; and electrophysiological products. It offers TruePhysio rapid exchange pressure microcatheter, VivoHeart intravascular ultrasound console, VivoCardio cardiovascular pressure measurement system, TRUEVISION HD imaging catheter, TrueCross microcatheter, TrueReach dual-lumen microcatheter, and TrueExtensio guide extension catheter. The company also provides clinical support and academic promotion related to its products, and engages in research and development, manufacturing, and commercialization of medical technologies. Insight Lifetech Co., Ltd. was incorporated in 2015 and is headquartered in Shenzhen, China.